MedPath

Lenalidomide Adherence in Older Adults

Terminated
Conditions
Multiple Myeloma
Registration Number
NCT03779555
Lead Sponsor
Washington University School of Medicine
Brief Summary

To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Age β‰₯65
  • Receiving lenalidomide for treatment of multiple myeloma.
  • Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
  • Able to read and understand English.
  • Able to understand and willing to sign an IRB-approved written informed consent document.
Exclusion Criteria
  • Estimated life expectancy <6 months.
  • Anticipated duration of lenalidomide therapy <3 months.
  • Residing in a nursing facility where their medications are administered to them OR patient reports they do not self-administer their own medications.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence rate as measured by the number of days in which the lenalidomide pill bottle was openThrough completion of study (estimated to be 3 months)

-Participants will be given a pill diary in which they will record if they opened the pill bottle without taking a medication (e.g. to ascertain remaining supply) to adjust the adherence rate accordingly

Secondary Outcome Measures
NameTimeMethod
Adherence rate as measured by a modified Brief Adherence Rating ScaleThrough completion of study (estimated to be 3 months)

* Participants will fill out a brief survey about taking lenalidomide and an estimate of their adherence using a visual analog scale

* Scored 0-100%, 0% = lenalidomide not taken on any days and 100% = lenalidomide taken every day

Trial Locations

Locations (1)

Washington University School of Medicine

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

Washington University School of Medicine
πŸ‡ΊπŸ‡ΈSaint Louis, Missouri, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.